Conversely, in liver cancer, CDDP-induced drug resistance correlates with lowered mTOR signaling with increased autophagy, as evidenced by elevated Beclin-1, increased LC3B-II, and reduced p62 [48,49]. The gene discussed is BECN1; the disease is liver cancer.